These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7198723)

  • 1. Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors.
    Globus M; Lerer B; Hamburger R; Belmaker RH
    Neuropharmacology; 1981 Nov; 20(11):1125-8. PubMed ID: 7198723
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock.
    Gulati A; Srimal RC; Dhawan KN; Dhawan BN
    Neuropharmacology; 1987 Dec; 26(12):1733-7. PubMed ID: 3437939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of nigral dopamine receptors?
    Glick SD; Crane LA
    Brain Res; 1978 Nov; 156(2):380-1. PubMed ID: 568507
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of apomorphine and haloperidol on "spontaneous" stereotyped licking behaviour in the Cebus monkey.
    Korsgaard S; Povlsen UJ; Randrup A
    Psychopharmacology (Berl); 1985; 85(2):240-3. PubMed ID: 3925490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
    Zharkovskiĭ AM; Allikmets LKh; Nurk AM
    Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats.
    Fuchs V; Coper H; Strauss S; Rommelspacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):133-7. PubMed ID: 3024028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the potential neuroleptic peptide des-tyrosine-gamma-endorphin and haloperidol on apomorphine-induced behavioural syndromes in rats and mice.
    Nickolson VJ; Berendsen HH
    Life Sci; 1980 Oct; 27(15):1377-85. PubMed ID: 7192353
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of central nervous system supersensitivity induced in rats by long-term haloperidol administration. I. pA2 determination.
    Palermo-Neto J; Bernardi MM; Saban R
    Pharmacology; 1984; 28(4):203-10. PubMed ID: 6539476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.